Kalota A - Search Results

1

Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression.

Sugita M, Kalota A, Gewirtz AM, Carroll M. Sugita M, et al. Among authors: kalota a. Leukemia. 2013 Apr;27(5):1207-10. doi: 10.1038/leu.2012.310. Epub 2012 Nov 6. Leukemia. 2013. PMID: 23183425 Free PMC article. No abstract available.

2

A prototype nonpeptidyl, hydrazone class, thrombopoietin receptor agonist, SB-559457, is toxic to primary human myeloid leukemia cells.

Kalota A, Gewirtz AM. Kalota A, et al. Blood. 2010 Jan 7;115(1):89-93. doi: 10.1182/blood-2009-06-227751. Epub 2009 Oct 30. Blood. 2010. PMID: 19880492 Free article.

3

Progress in the development of nucleic acid therapeutics.

Kalota A, Dondeti VR, Gewirtz AM. Kalota A, et al. Handb Exp Pharmacol. 2006;(173):173-96. doi: 10.1007/3-540-27262-3_9. Handb Exp Pharmacol. 2006. PMID: 16594616 Review.

4

Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survival.

Kalota A, Selak MA, Garcia-Cid LA, Carroll M. Kalota A, et al. PLoS One. 2015 Apr 27;10(4):e0126691. doi: 10.1371/journal.pone.0126691. eCollection 2015. PLoS One. 2015. PMID: 25915523 Free PMC article.

5

Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.

Kim DH, Kim EJ, Kalota A, Gewirtz AM, Glickson J, Shogen K, Lee I. Kim DH, et al. Among authors: kalota a. Adv Exp Med Biol. 2007;599:53-9. doi: 10.1007/978-0-387-71764-7_8. Adv Exp Med Biol. 2007. PMID: 17727247

6

Progress in the development of nucleic acid therapeutics for cancer.

Kalota A, Shetzline SE, Gewirtz AM. Kalota A, et al. Cancer Biol Ther. 2004 Jan;3(1):4-12. doi: 10.4161/cbt.3.1.517. Epub 2004 Jan 18. Cancer Biol Ther. 2004. PMID: 14726654 Free article. Review.

7

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.

Shetzline SE, Rallapalli R, Dowd KJ, Zou S, Nakata Y, Swider CR, Kalota A, Choi JK, Gewirtz AM. Shetzline SE, et al. Among authors: kalota a. Blood. 2004 Sep 15;104(6):1833-40. doi: 10.1182/blood-2003-10-3577. Epub 2004 Jun 8. Blood. 2004. PMID: 15187020 Free article.

8

Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.

Lee I, Kalota A, Gewirtz AM, Shogen K. Lee I, et al. Among authors: kalota a. Anticancer Res. 2007 Jan-Feb;27(1A):299-307. Anticancer Res. 2007. PMID: 17352247 Free article.

9

The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.

Zhao H, Kalota A, Jin S, Gewirtz AM. Zhao H, et al. Among authors: kalota a. Blood. 2009 Jan 15;113(3):505-16. doi: 10.1182/blood-2008-01-136218. Epub 2008 Sep 25. Blood. 2009. PMID: 18818396 Free PMC article.

10

c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.

Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM. Jin S, et al. Among authors: kalota a. J Clin Invest. 2010 Feb;120(2):593-606. doi: 10.1172/JCI38030. Epub 2010 Jan 19. J Clin Invest. 2010. PMID: 20093773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters